In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity
Monoclonal antibody (mAb) drugs offer a number of valuable treatments. Many newly developed mAb drugs include artificial modification of amino acid sequences from human origin, which may cause higher immunogenicity to induce anti-drug antibodies (ADA). If the immunogenicity of a new candidate can be...
Main Authors: | Shunsuke Ito, Tatsuya Ikuno, Masayuki Mishima, Mariko Yano, Toshiko Hara, Taichi Kuramochi, Zenjiro Sampei, Tetsuya Wakabayashi, Mitsuyasu Tabo, Shuichi Chiba, Chiyomi Kubo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Journal of Immunotoxicology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/1547691X.2019.1604586 |
Similar Items
-
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
by: Yoshiyuki Arata, et al.
Published: (2023-12-01) -
Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells
by: Sivan Cohen, et al.
Published: (2021-01-01) -
A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus
by: Mohammad Mostafa Pourseif, et al.
Published: (2018-01-01) -
Memory T follicular helper CD4 T cells
by: J. Scott eHale, et al.
Published: (2015-02-01) -
In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens
by: Sepideh Parvizpour, et al.
Published: (2019-01-01)